A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
|
journal
|
April 2011 |
Follicular B helper T cells in antibody responses and autoimmunity
|
journal
|
November 2005 |
Proliferating Active Cells, Lymphocyte Subsets, and Dendritic Cells in Recurrent Tonsillitis: Their Effect on Hypertrophy
|
journal
|
May 2008 |
Blood Microcirculation in the Lymph node During the Primary Immune Response
|
journal
|
October 1972 |
Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART
|
journal
|
February 2005 |
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
|
journal
|
October 2011 |
Viral Blips May Not Need a Trigger: How Transient Viremia Can Arise in Deterministic In-Host Models
|
journal
|
January 2014 |
Tracking episomal HIV DNA: implications for viral persistence and eradication of HIV
|
journal
|
January 2013 |
Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis
|
journal
|
April 2012 |
Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
|
journal
|
August 2013 |
Lymphoid Fibrosis Occurs in Long-Term Nonprogressors and Persists With Antiretroviral Therapy but May Be Reversible With Curative Interventions
|
journal
|
October 2014 |
Florid Reactive Follicular Hyperplasia in Elderly Patients. A Clinicopathological Study of 23 Cases
|
journal
|
January 1998 |
Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: A clinicopathological and immunohistological study of 21 cases
|
journal
|
April 2000 |
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient
|
journal
|
January 1999 |
The paradox of the immune response in HIV infection: When inflammation becomes harmful
|
journal
|
February 2013 |
Excitability in the host–pathogen interactions of HIV infection and emergence of viral load blips
|
journal
|
January 2013 |
Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
|
journal
|
October 2009 |
Modeling HIV persistence, the latent reservoir, and viral blips
|
journal
|
September 2009 |
Lymphoid tissue viral burden and duration of viral suppression in plasma
|
journal
|
January 2001 |
Transient Viremia, Plasma Viral Load, and Reservoir Replenishment in HIV-Infected Patients on Antiretroviral Therapy
|
journal
|
January 2007 |
Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy
|
journal
|
September 2005 |
Certifying spatially uniform behavior in reaction–diffusion PDE and compartmental ODE systems
|
journal
|
June 2011 |
Viral Blip Dynamics during Highly Active Antiretroviral Therapy
|
journal
|
November 2003 |
Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals: Immune activation and risk of viral blips
|
journal
|
February 2014 |
Influence of Episodes of Intermittent Viremia (“Blips”) on Immune Responses and Viral Load Rebound in Successfully Treated HIV-Infected Patients
|
journal
|
January 2013 |
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen
|
journal
|
January 2005 |
Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence
|
journal
|
September 2004 |
Residual Viremia Is Preceding Viral Blips and Persistent Low-Level Viremia in Treated HIV-1 Patients
|
journal
|
October 2014 |
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
|
journal
|
September 2012 |
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
|
journal
|
August 2010 |
Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients
|
journal
|
January 2010 |
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART
|
journal
|
January 2001 |
Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy
|
journal
|
November 2014 |
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy
|
journal
|
January 2012 |
Tissue Says Blood Is Misleading, Confusing HIV Cure Efforts
|
journal
|
December 2011 |
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics
|
journal
|
July 2012 |
Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection
|
journal
|
October 2004 |
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
|
journal
|
January 2014 |
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
|
journal
|
March 2010 |
Benign lymphadenopathies
|
journal
|
January 2013 |
Short Communication: HIV Blips While on Antiretroviral Therapy Can Indicate Consistently Detectable Viral Levels Due to Assay Underreporting
|
journal
|
December 2013 |
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients
|
journal
|
January 2003 |
Modelling HIV-1 2-LTR dynamics following raltegravir intensification
|
journal
|
July 2013 |
Viral Blip Dynamics during Highly Active Antiretroviral Therapy
|
journal
|
November 2003 |
Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection
|
journal
|
October 2004 |
Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART
|
journal
|
January 2001 |
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients
|
journal
|
January 2003 |
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen Restoration after involution and CD4 cell depletion in an AIDS patient
|
journal
|
January 1999 |
Lymphoid tissue viral burden and duration of viral suppression in plasma
|
journal
|
January 2001 |
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification
|
journal
|
March 2014 |
Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: A clinicopathological and immunohistological study of 21 cases
|
journal
|
April 2000 |